IDEAL_ANSWER:
- Mothers with a CYP2D6 ultrarapid metabolizer phenotype may expose their infants to risk of adverse events when taking codeine while breastfeeding, by producing more of the active metabolite, morphine.

EXACT_ANSWER:
- CYP2D6